Europe — EMA

Olmesartán/Hidroclorotiazida Stada (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartán/Hidroclorotiazida Stada, is a angiotensin II receptor blocker presented as a tablet for oral use.

Olmesartan Medoxomil, Hydrochlorothiazide

Request sourcing

Pack/s

What is Olmesartan Medoxomil, Hydrochlorothiazide?

Olmesartan medoxil, the active ingredient in Olmesartán/Hidroclorotiazida Stada, is a angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is intended for adult patients. GNH USA supplies Olmesartán/Hidroclorotiazida Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartán/Hidroclorotiazida Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olmesartan Medoxomil, Hydrochlorothiazide used for?

Olmesartan/Hydrochlorothiazide is used for managing blood pressure through the renin‑angiotensin system and diuretic pathways. - Hypertension: Lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure with reduced ejection fraction: Assists in fluid management and blood‑pressure control when combined with other therapies. - Diabetic nephropathy protective effect against renal function decline in type 2 diabetes. - Chronic kidney d t t t. - g -

What are the side effects of Olmesartan Medoxomil, Hydrochlorothiazide?

Olmesartan/Hydro

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →